These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Role of Clostridium difficile infection in the relapse of ulcerative colitis]. Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034 [TBL] [Abstract][Full Text] [Related]
12. [Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin]. Tordjman R; Benfiguig K; Eugène C; Mitry E; Merrer J Gastroenterol Clin Biol; 1995 May; 19(5):545-6. PubMed ID: 7590012 [No Abstract] [Full Text] [Related]
13. Metronidazole: an alternate therapy for antibiotic-associated colitis. Cherry RD; Portnoy D; Jabbari M; Daly DS; Kinnear DG; Goresky CA Gastroenterology; 1982 May; 82(5 Pt 1):849-51. PubMed ID: 7060906 [TBL] [Abstract][Full Text] [Related]
14. [Relapsing infections with Clostridium difficile]. Visser WE; Dingemans-Dumas AM; Bac DJ Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of Clostridium difficile in pseudomembranous and antibiotic-associated colitis in north India. Ayyagari A; Sharma P; Venkateswarlu ; Mehta S; Agarwal KC J Diarrhoeal Dis Res; 1986 Sep; 4(3):157-60. PubMed ID: 3584906 [No Abstract] [Full Text] [Related]
16. Role of Clostridium difficile in a case of nonantibiotic-associated pseudomembranous colitis. Peikin SR; Galdibini J; Bartlett JG Gastroenterology; 1980 Nov; 79(5 Pt 1):948-51. PubMed ID: 7419019 [TBL] [Abstract][Full Text] [Related]
17. The changing face of Clostridium difficile: what treatment options remain? Shen EP; Surawicz CM Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108 [TBL] [Abstract][Full Text] [Related]